NASDAQ:SQNM - Sequenom Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous Close$2.39
Today's Range$2.39 - $2.39
52-Week Range$0.82 - $2.53
VolumeN/A
Average Volume1.27 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Sequenom, Inc. is a life sciences company. The Company serves patients and physicians by providing early patient management information. The Company operates through Sequenom Laboratories segment. It conducts its business as a molecular diagnostics clinical laboratory located in San Diego, California and Raleigh-Durham, North Carolina. Its testing focus is on prenatal health that includes molecular-based laboratory developed tests (LDTs). The Company's diagnostic services are provided through its subsidiary, Sequenom Center for Molecular Medicine LLC (SCMM), doing business as Sequenom Laboratories. Sequenom Laboratories develops and validates its tests to be used as a testing service to physicians. Sequenom Laboratories is focused on developing and offering a menu of tests for prenatal continuum of care. The Sequenom Laboratories' test offerings in the prenatal market include MaterniT21 PLUS LDT, HerediT CF test, SensiGene RhD test, VisibiliT test and Test Send-out Agreements.

Receive SQNM News and Ratings via Email

Sign-up to receive the latest news and ratings for SQNM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry N/A
Sub-IndustryLife Sciences Tools & Services
SectorN/A
Current SymbolNASDAQ:SQNM
Previous Symbol
CUSIP81733740
Phone+1-858-2029000

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Employees434
Outstanding SharesN/A
Market Cap$0.00
OptionableNot Optionable

Sequenom (NASDAQ:SQNM) Frequently Asked Questions

What is Sequenom's stock symbol?

Sequenom trades on the NASDAQ under the ticker symbol "SQNM."

Has Sequenom been receiving favorable news coverage?

News articles about SQNM stock have trended somewhat positive this week, InfoTrie Sentiment reports. The research firm ranks the sentiment of press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Sequenom earned a media sentiment score of 1.7 on InfoTrie's scale. They also gave news articles about the biotechnology company a news buzz of 7.0 out of 10, indicating that recent press coverage is likely to have an effect on the stock's share price in the near term.

How do I buy shares of Sequenom?

Shares of SQNM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Sequenom's official website?

The official website for Sequenom is https://www.sequenom.com/.

How can I contact Sequenom?

Sequenom's mailing address is 3595 John Hopkins Ct, SAN DIEGO, CA 92121-1121, United States. The biotechnology company can be reached via phone at +1-858-2029000.


MarketBeat Community Rating for Sequenom (NASDAQ SQNM)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  220 (Vote Outperform)
Underperform Votes:  177 (Vote Underperform)
Total Votes:  397
MarketBeat's community ratings are surveys of what our community members think about Sequenom and other stocks. Vote "Outperform" if you believe SQNM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SQNM will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/18/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel